NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 16 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $12,090 | +2.5% | 13,000 | 0.0% | 0.00% | – |
Q4 2022 | $11,798 | -1.7% | 13,000 | 0.0% | 0.00% | – |
Q3 2022 | $12,000 | -53.8% | 13,000 | -53.6% | 0.00% | – |
Q2 2022 | $26,000 | -42.2% | 28,000 | -3.4% | 0.00% | – |
Q1 2021 | $45,000 | -15.1% | 29,000 | 0.0% | 0.00% | – |
Q4 2020 | $53,000 | +10.4% | 29,000 | -6.5% | 0.00% | – |
Q3 2020 | $48,000 | – | 31,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 9,000,000 | $135,324,000 | 1.71% |
DeepCurrents Investment Group LLC | 21,930,000 | $33,750,000 | 1.16% |
WOLVERINE ASSET MANAGEMENT LLC | 44,534,000 | $69,564,000 | 0.59% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,208,000 | 0.38% |
Context Capital Management, LLC | 2,000 | $3,084,000 | 0.30% |
ZAZOVE ASSOCIATES LLC | 1,500,000 | $2,276,000 | 0.27% |
Polar Asset Management Partners Inc. | 17,500,000 | $26,683,000 | 0.26% |
CSS LLC/IL | 2,500,000 | $3,780,000 | 0.16% |
Verition Fund Management LLC | 7,486,000 | $11,543,000 | 0.13% |
PFM Health Sciences, LP | 2,000,000 | $3,032,000 | 0.09% |